Vivos (RDGL) Gross Margin Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -265.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -65.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 610.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -359.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 58.00 |
| 10 | Vivos | - | - | -3,105.00 | 9,326.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9,326.00 |
| Sep 30, 2025 | -70,363.00 |
| Jun 30, 2025 | -25,183.00 |
| Mar 31, 2025 | -62.00 |
| Sep 30, 2024 | -7,838.00 |
| Jun 30, 2024 | 5,861.00 |
| Mar 31, 2024 | -773.00 |
| Sep 30, 2023 | 20,054.00 |
| Jun 30, 2023 | -11,924.00 |
| Mar 31, 2023 | -10,252.00 |
| Sep 30, 2022 | -16,023.00 |
| Mar 31, 2018 | 58,442.00 |
| Mar 31, 2017 | -34,933.00 |
| Sep 30, 2016 | -162,789.00 |
| Mar 31, 2016 | -28,872.00 |
| Mar 31, 2015 | 103.00 |
| Mar 31, 2014 | 1,411.00 |
| Sep 30, 2013 | -7,311.00 |
| Mar 31, 2013 | -707.00 |
| Dec 31, 2012 | -6,117.00 |
| Sep 30, 2012 | 1,733.00 |
| Jun 30, 2012 | -20,001.00 |
| Mar 31, 2012 | 2,843.00 |
| Dec 31, 2011 | -1,820.00 |